Key Account Manager
Arrowhead Pharmaceuticals
June 29, 2026
On-site
Dallas, TX
Sales
Responsibilities:
- Develop and execute comprehensive account strategies across priority IDNs, health systems, and complex accounts within an assigned geography.
- Build institutional access through formulary engagement, protocol development, and clinical pathway integration.
- Drive integration of Plozasiran into treatment algorithms, order sets, and clinical workflows with key institutional decision-makers.
- Own multi-year account growth plans, including system-level partnership development and sustained execution against account objectives.
- Use adoption, access, and performance data to segment and prioritize accounts; identify highest-impact opportunities and barriers.
- Monitor account-level adoption metrics and proactively address access barriers to accelerate pull-through.
- Maintain account planning discipline (regular business reviews and updated stakeholder maps).
- Build and maintain trusted relationships with pharmacy leadership, population health leaders, value analysis committees, and clinical champions.
- Engage compliantly in value-based discussions (health economics, outcomes, real-world evidence).
- Ensure alignment between enterprise decision-makers and field-level prescriber activation efforts.
- Navigate institutional approval processes with strategic agility.
- Develop clinical fluency in FCS/ApoC-III biology and the evidence base for Plozasiran; educate stakeholders on diagnosis and patient identification.
- Collaborate with Health IT to support patient identification tools and workflow integration.
- Partner with Rare Disease Specialists and Regional Sales Directors; collaborate with Market Access, Marketing, Medical Affairs, and Commercial Ops.
- Provide field insights on competitive dynamics, formulary positioning, and access trends.
- Own account-level performance targets; monitor forecasting and growth indicators; maintain CRM documentation and reporting.
- Conduct enterprise engagements in compliance with laws, regulations, and ethical standards.
Qualifications:
- Minimum 5+ years of pharmaceutical/biotech experience required.
- Experience in IDN, health system, or complex account management required.
- Demonstrated ability to navigate and influence formulary/protocol/pathway decisions in complex institutions.
- Track record of consistent performance and territory growth in field-based roles.
- Specialty, rare disease, or cardiometabolic therapeutic area experience preferred.
Skills/Competencies:
- Strong executive presence; advanced account management and enterprise planning.
- Solid understanding of health system economics, reimbursement, and access pathways.
- Ability to translate complex clinical/health economic data into value narratives.
- Strong analytical and data-driven decision-making.
- Resilience, adaptability, sound judgment; collaborative mindset.
- Exceptional communication, negotiation, and stakeholder navigation.
Benefits:
- Competitive base salary: $190,000 - $210,000 plus incentive compensation.
- Equity (RSUs) eligibility and car allowance program.
- Comprehensive benefits package including health, dental, vision, and 401(k).
- Develop and execute comprehensive account strategies across priority IDNs, health systems, and complex accounts within an assigned geography.
- Build institutional access through formulary engagement, protocol development, and clinical pathway integration.
- Drive integration of Plozasiran into treatment algorithms, order sets, and clinical workflows with key institutional decision-makers.
- Own multi-year account growth plans, including system-level partnership development and sustained execution against account objectives.
- Use adoption, access, and performance data to segment and prioritize accounts; identify highest-impact opportunities and barriers.
- Monitor account-level adoption metrics and proactively address access barriers to accelerate pull-through.
- Maintain account planning discipline (regular business reviews and updated stakeholder maps).
- Build and maintain trusted relationships with pharmacy leadership, population health leaders, value analysis committees, and clinical champions.
- Engage compliantly in value-based discussions (health economics, outcomes, real-world evidence).
- Ensure alignment between enterprise decision-makers and field-level prescriber activation efforts.
- Navigate institutional approval processes with strategic agility.
- Develop clinical fluency in FCS/ApoC-III biology and the evidence base for Plozasiran; educate stakeholders on diagnosis and patient identification.
- Collaborate with Health IT to support patient identification tools and workflow integration.
- Partner with Rare Disease Specialists and Regional Sales Directors; collaborate with Market Access, Marketing, Medical Affairs, and Commercial Ops.
- Provide field insights on competitive dynamics, formulary positioning, and access trends.
- Own account-level performance targets; monitor forecasting and growth indicators; maintain CRM documentation and reporting.
- Conduct enterprise engagements in compliance with laws, regulations, and ethical standards.
Qualifications:
- Minimum 5+ years of pharmaceutical/biotech experience required.
- Experience in IDN, health system, or complex account management required.
- Demonstrated ability to navigate and influence formulary/protocol/pathway decisions in complex institutions.
- Track record of consistent performance and territory growth in field-based roles.
- Specialty, rare disease, or cardiometabolic therapeutic area experience preferred.
Skills/Competencies:
- Strong executive presence; advanced account management and enterprise planning.
- Solid understanding of health system economics, reimbursement, and access pathways.
- Ability to translate complex clinical/health economic data into value narratives.
- Strong analytical and data-driven decision-making.
- Resilience, adaptability, sound judgment; collaborative mindset.
- Exceptional communication, negotiation, and stakeholder navigation.
Benefits:
- Competitive base salary: $190,000 - $210,000 plus incentive compensation.
- Equity (RSUs) eligibility and car allowance program.
- Comprehensive benefits package including health, dental, vision, and 401(k).